產(chǎn)品詳情
簡(jiǎn)單介紹：
Anti-CRMP5抗體產(chǎn)品質(zhì)量穩(wěn)定，實(shí)驗(yàn)效果明顯，貨期快，價(jià)格優(yōu)惠，歡迎垂詢訂購(gòu)！我公司長(zhǎng)期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗(yàn)所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實(shí)驗(yàn)抗體。Anti-CRMP5抗體用于**組化實(shí)驗(yàn),WB實(shí)驗(yàn),相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-CRMP5
Cat. Number:
Anti-CRMP5抗體KL-8283R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
The collapsin response mediator protein (CRMP) family of proteins (also referred to as ULIP6) are a group of neurologic proteins that have been found to play key roles in growth cone guidance during neural development. Anti-CRMP5抗體CRMP5 has relatively low sequence homology with the other four members of the CRMP family. CRMP5 is expressed in the developing nervous system in an expression pattern that resembles CRMP2 and has a peak expression during the first postnatal week. Elevated levels of autoantibody to CRMP5 have been shown to be linked paraneoplastic autoimmune optic neuritis and other paraneoplastic neoplasms. Auto-immunity against CRMP5 expression (predominantly the N-terminal epitopes) is also being investigated as an oncological marker in the respiratory system and in the thymus.
Also known as:
Collapsin response Anti-CRMP5抗體mediator protein 5; CRAM; CRMP 3 associated molecule; CRMP 5; CRMP3 associated molecule; Dihydropyrimidinase like 5; Dihydropyrimidinase related protein 5; DPYS L5; DPYSL 5; DPYSL5; DRP 5; DRP5; FLJ45383; Ulip 6; Ulip6; ULIP6 protein.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Dog, Pig, Cow, Rabbit, .
●
Immunogen: KLH conjugated synthetic peptide derived from human CRMP5.
●
Predicted Molecular Weight: 65kDa.
Storage:
Shipped at 4℃, StoreAnti-CRMP5抗體 at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working Anti-CRMP5抗體dilutions must be determined by the end user.
Not yet tested in other applications.
Optimal working Anti-CRMP5抗體dilutions must be determined by the end user.
kl893Hu01 血管內(nèi)皮生長(zhǎng)因子受體3(VEGFR3)多克隆抗體 Polyclonal Antibody to Vascular Endothelial Growth Factor Receptor 3 (VEGFR3)
kl893Mu01 血管內(nèi)皮生長(zhǎng)因子受體3(VEGFR3)多克隆抗體 Polyclonal Antibody to Vascular Endothelial Growth Factor Receptor 3 (VEGFR3)
kl893Ra01 血管內(nèi)皮生長(zhǎng)因子受體3(VEGFR3)多克隆抗體 Polyclonal Antibody to Vascular Endothelial Growth Factor Receptor 3 (VEGFR3)
kl895Hu01 甘露聚糖結(jié)合凝集素關(guān)聯(lián)絲氨酸蛋白酶1(MASP1)多克隆抗體 Polyclonal Antibody to Mannose Associated Serine Protease 1 (MASP1)
kl895Mu01 甘露聚糖結(jié)合凝集素關(guān)聯(lián)絲氨酸蛋白酶1(MASP1)多克隆抗體 Polyclonal Antibody to Mannose Associated Serine Protease 1 (MASP1)
kl897Hu01 胰島素降解酶(IDE)多克隆抗體 Polyclonal Antibody to Insulin Degrading Enzyme (IDE)
kl897Mu01 胰島素降解酶(IDE)多克隆抗體 Polyclonal Antibody to Insulin Degrading Enzyme (IDE)
kl897Ra01 胰島素降解酶(IDE)多克隆抗體 Polyclonal Antibody to Insulin Degrading Enzyme (IDE)
kl901Hu01 激活素受體樣激酶1(ALK1)多克隆抗體 Polyclonal Antibody to Activin Receptor Like Kinase 1 (ALK1)
kl902Hu01 心肌鈣黏蛋白(CDHH)多克隆抗體 Polyclonal Antibody to Cadherin, Heart (CDHH)
kl903Hu01 纖維膠凝蛋白3(FCN3)多克隆抗體 Polyclonal Antibody to Ficolin 3 (FCN3)
kl904Hu01 血小板膜糖蛋白Ⅵ(GP6)多克隆抗體 Polyclonal Antibody to Glycoprotein VI, Platelet (GP6)
kl905Hu01 白介素7受體(IL7R)多克隆抗體 Polyclonal Antibody to Interleukin 7 Receptor (IL7R)
kl905Ra01 白介素7受體(IL7R)多克隆抗體 Polyclonal Antibody to Interleukin 7 Receptor (IL7R)
